ADVITOS GmbH

ADVITOS GmbH is a German-based startup that has developed the CE-marked and worldwide patented ADVOS technology. With the slogan "ADVOS - ADVanced Organ Support," the company offers a groundbreaking therapy that integrates multi-organ support in one single device. This innovative technology enhances the survival of ICU patients by simultaneously supporting the detoxification functions of the liver, lung, and kidney. The solution allows for the elimination of various toxins, including water-soluble toxins, protein-bound toxins, and CO2, as well as the correction of acid-base imbalances through patient-specific adjustment of the blood pH value. Since its establishment in 2005, ADVITOS GmbH has made significant strides in the medical industry, with its ADVOS therapy being utilized in intensive care units at 20 leading university hospitals throughout Germany. The company received a substantial €20.00MVenture Round investment on 10 June 2021 from prominent investors including Crédit Mutuel Innovation and The European Innovation Council, demonstrating growing confidence in the company's vision and potential. With its innovative technology gaining traction, ADVITOS GmbH is poised to expand its presence in the international market, positioning it as a compelling investment opportunity in the healthcare sector.